Cell Line Development Market size is projected to reach USD 7.45 billion by 2023; as per the latest research report by Global Market Insights, Inc. Growing demand for novel drugs, biosimilars, and vaccines due to patent expiration of blockbuster drugs, and increasing investment in biotechnology industry, along with favorable government policies is likely to drive global cell line development market size.
Global cell line development market revenue pegged at USD 2.81 billion in 2015 and is likely to grow at a CAGR of 13% over the forecast period. Rising incidences of cancer and auto immune disorders requiring effective and faster therapeutics are key factors attributing to the growth of the cell line development market over the forecast period. Furthermore, favorable government initiatives aimed at improving healthcare infrastructure and the development of novel technologies for cell line development are expected to present this market with future growth opportunities.
Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/429
Accessories and consumables are forecast to remain a very lucrative product segment of the market, estimated to grow at a healthy 16.3% CAGR, from 2016 to 2023. Rise in number of research and development activity for biosimilars and biologic products is anticipated to boost the demand for productive cell lines for large-scale manufacturing practices.
Over the past few years, approximately 15 new therapeutic and recombinant proteins are being approved annually by the U.S. Food and Drug Administration (FDA). Moreover, increasing number of monoclonal antibodies based viable therapies and introduction of Mabs-based modalities are other factors expected to contribute towards the growth of monoclonal antibodies market.
The industry is witnessing introduction of technologically advanced cell line development processes, novel technologies such as automated screening methods, cell line engineering, enhanced expression systems, improved process monitoring, and use of disposable apparatus are some factors contributing to cell line development market growth.
APAC pose a significant growth opportunity, with target market likely to exceed USD 1.8 billion, by 2023. Presence of supportive government initiatives and increasing investments by manufacturers and government in biotechnology sector and high untapped opportunities are the important factors anticipating the growth of Asia Pacific. Latin American region is also expected to offer cell line development market with lucrative growth opportunities in the coming years, due to presence of high unmet medical needs and rapidly improving healthcare infrastructure.
To access sample pages or view this report titled, “Cell Line Development Market Size By Product [Reagents & Media, Equipment (Incubator, Centrifuge, Bioreactor, Microscope), Accessories & Consumables], By Source [Mammalian, Non-Mammalian (Insects, Amphibians)], By Cell Line [Recombinant, Hybridomas, Continuous Cell Line, Primary Cell Line], By Application [Bioproduction, Drug Discovery, Toxicity Testing, Tissue Engineering, Research] Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, China, India, Japan, Brazil, Mexico, South Africa), Application Potential, Competitive Market Share & Forecast, 2016 - 2023” in detail along with the table of contents, please click on the link below:
Key insights from the report include:
Last updated on: 14/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.